US Patent Issued to CUBOPHARM on Jan. 13 for "Liquid crystalline dosage form for administering a statin" (Australian Inventors)

ALEXANDRIA, Va., Jan. 13 -- United States Patent no. 12,521,350, issued on Jan. 13, was assigned to CUBOPHARM PTY LTD (Karingal, Australia).

"Liquid crystalline dosage form for administering a statin" was invented by Gregory Yu Foo Szto (Melbourne, Australia), Tomer Madmon (Melbourne, Australia) and David Kannar (Melbourne, Australia).

According to the abstract* released by the U.S. Patent & Trademark Office: "A composition including an amphiphilic compound capable of self-assembling into liquid crystalline particles and a statin for systemic administration via oral mucosa. A method of lowering blood cholesterol levels in a subject comprising administering the self-assembling liquid crystalline particles and statin via oral mucosa. Prefer...